Pravastatin prolongs graft survival in an allogeneic rat model of orthotopic single lung transplantation☆
Author(s) -
Y LI,
T. David Koster,
C. Mörike,
S VHORSTEN,
Ulrich Martin,
Michael Bäder,
A HAVERICH,
Amparo Querol
Publication year - 2006
Publication title -
european journal of cardio-thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 133
eISSN - 1873-734X
pISSN - 1010-7940
DOI - 10.1016/j.ejcts.2006.03.072
Subject(s) - pravastatin , transplantation , cd8 , lung transplantation , peripheral blood mononuclear cell , il 2 receptor , medicine , flow cytometry , immunology , andrology , t cell , immune system , pharmacology , biology , in vitro , biochemistry , cholesterol
MHC class II molecules play central roles in immune recognition and rejection. As statins have been shown to inhibit the production of these molecules, we analyzed the possible immunosuppressive effect of pravastatin, using our rat model of orthotopic lung transplantation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom